Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
12/1996
12/18/1996EP0748313A1 Cytokine inhibiting imidazole substituted hydroxamic acid derivatives
12/18/1996EP0748312A1 Bicyclic carbamates as leukotriene d4 antagonists
12/18/1996EP0748311A1 Therapeutic benzonitriles
12/18/1996EP0748310A1 Diesters of carbonic acid endowed with antiviral and anti-inflammatory activity
12/18/1996EP0635011B1 Hydrazide derivatives of 3,4-dihydro-2h-1-benzopyrans
12/18/1996EP0526598B1 New pharmacologically active catechol derivatives
12/18/1996CN1138325A Anellated dihydropyridines and their use in the production of pharmaceutical preparations
12/18/1996CN1138324A Anellated dihydropyridines and their use in the production of pharmaceutical preparations
12/18/1996CN1138037A Adhesion receptor antagonists
12/18/1996CN1033585C Preparation of 1,2,4-triazolo(1,5-a) pyrimidine derivatives
12/17/1996US5585492 LTA4 Hydrolase inhibitors
12/17/1996US5585486 Peptidic ketones as interleukin-1β-converting enzyme inhibitors
12/17/1996US5585390 Alpha-amino acid compounds
12/17/1996US5585385 Heterocyclic compounds, their production and use as tachykinin reactor antagonists
12/17/1996US5585372 Tricyclic cefem sulphones
12/17/1996US5585357 Heteroaryloxymethyl ketones as interleukin-1βconverting enzyme inhibitors
12/17/1996US5585089 Humanized immunoglobulins
12/14/1996CA2178691A1 Oral formulations of s(+)-ibuprofen
12/14/1996CA2178686A1 Oral formulations of s(+)-etodolac
12/12/1996WO1996039522A1 Human chemokine beta-11 and human chemokine alpha-1
12/12/1996WO1996039515A1 Human vascular endothelial growth factor 2
12/12/1996WO1996039503A1 C5a RECEPTOR ANTAGONISTS HAVING SUBSTANTIALLY NO AGONIST ACTIVITY AND METHODS FOR PREPARATION
12/12/1996WO1996039499A1 TNF-α RIBOZYMES, TNF-α RIBOZYME BINDING PROTEIN AND DEGRADATION RESISTANT mRNA DERIVATIVES LINKED TO TNF-α RIBOZYMES
12/12/1996WO1996039485A1 Human hepatoma-derived growth factor-2
12/12/1996WO1996039442A1 G-protein receptor htnad29
12/12/1996WO1996039408A1 TRICYCLIC 5,6-DIHYDRO-9H-PYRAZOLO[3,4-c]-1,2,4-TRIAZOLO[4,3-α]PYRIDINES
12/12/1996WO1996039400A1 Amino-substituted thiadiazoles, pyrimidines, triazines or triazoles useful as ctf receptor antagonists
12/12/1996WO1996039383A1 Substituted benzene-fused hetero- and carbocyclics as neurokinin antagonists
12/12/1996WO1996039154A1 Oligonucleotides having phosphorothioate linkages of high chiral purity
12/12/1996WO1996039153A2 Use of di-beta-d-glucopyranosylamine compounds for controlling inflammatory reactions, and method of synthesis
12/12/1996WO1996039145A1 Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of her-2 autophosphorylation properties
12/12/1996WO1996034010A3 Inhibitors of farnesyl-protein transferase
12/12/1996WO1996033730A3 Chemokine binding protein and methods of use therefor
12/12/1996WO1996033282A3 High efficiency ex vivo transduction of cells by high titer recombinant retroviral preparations
12/12/1996WO1996020187A3 Esters and amides of non-steroidal anti-inflammatory carboxylic acids which may be used as anti-oxidants, 5-lipoxygenase inhibitors and non-steroidal anti-inflammatory products
12/12/1996WO1996011949A3 Analogs of keratinocyte growth factor
12/12/1996CA2562162A1 Human g-protein chemokine receptor hdgnr10
12/12/1996CA2223733A1 Human hepatoma-derived growth factor-2
12/12/1996CA2223307A1 Amino-substituted thiadiazoles, pyrimidines, triazines or triazoles useful as ctf receptor antagonists
12/12/1996CA2223239A1 Substituted benzene-fused hetero- and carbocyclics as neurokinin antagonists
12/12/1996CA2223103A1 Oligonucleotides having phosphorothioate linkages of high chiral purity
12/12/1996CA2222915A1 Use of di-beta-d-glucopyranosylamine compounds for controlling inflammatory reactions, and method of synthesis
12/12/1996CA2222280A1 Human chemokine beta-11 and human chemokine alpha-1
12/12/1996CA2221706A1 G-protein receptor htnad29
12/11/1996EP0747353A2 Indole derivatives
12/11/1996EP0747347A1 RARy-specific retinobenzoic acid derivatives
12/11/1996EP0746619A1 Human phosphodiesterase type ivc, and its production and use
12/11/1996EP0746567A1 Novel opioid peptides for the treatment of pain and use thereof
12/11/1996EP0746557A1 Intracellular signalling mediators
12/11/1996EP0746551A1 Optically pure 4-aryl-2-hydroxytetronic acids
12/11/1996EP0746547A1 2-(4-methoxyphenoxy)-3-pyridineamine, its preparation and its use as anti-inflammatory agent
12/11/1996EP0746542A1 Therapeutic benzonitriles
12/11/1996EP0746329A1 Anti-inflammatory factor, method of isolation, and use
12/11/1996EP0746324A1 Method of combatting osteoporosis and other disease states in mammalian subjects, utilizing organic boron compounds
12/11/1996EP0746323A1 Inhibitors of phosphoinositide-specific phospholipase c
12/11/1996EP0746312A1 Guanylhydrazones for treating inflammatory conditions
12/11/1996EP0635010B1 Novel cardioprotective agents
12/11/1996EP0496832B1 Inhibition of padgem-mediated cell binding
12/11/1996CN1137752A DI-tert-butylphenol compounds useful as anti-inflammatory agents
12/11/1996CN1137405A Chinese herbal medicine composition for preparing non-dependence anti-cancer pain-alleviating drug and preparation thereof
12/10/1996US5583242 Use of phosphotyrosine phosphatase inhibitors for controlling cellular proliferation
12/10/1996US5583222 Antiinflammatory agents for treatment of skin disorders
12/10/1996US5583221 Antiinflammatory agents, cardiovascular disorders, viricides, fungicides
12/10/1996US5583152 Method for treating vasospastic cardiovascular diseases heterocyclic amide derivatives
12/10/1996US5583143 Administering a 2,3-diaryl-1-benzopyran
12/10/1996US5583135 Heterotricyclic derivatives, process for their preparation and pharmaceutical compositions containing them
12/10/1996US5583105 Oral pharmaceutical preparation
12/10/1996US5582995 Methods of screening for compounds which inhibit the direct binding of Ras to Raf
12/10/1996US5582823 Methods of treating bacterial inflammation and granulocytopoiesis by administering human pluripotent granulocyte colony-stimulating factor
12/10/1996CA1338776C Use of transglutaminases as immunosuppressants
12/07/1996CA2175854A1 Rar(gamma)-specific retinobenzoic acid derivatives
12/05/1996WO1996038579A1 High-affinity oligonucleotide ligands to growth factors
12/05/1996WO1996038559A1 Chemokine n-terminal deletion mutations
12/05/1996WO1996038457A1 Methods for in vivo reduction of nitric oxide levels and compositions useful therefor
12/05/1996WO1996038442A1 Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors
12/05/1996WO1996038434A1 Tricyclic inhibitors of matrix metalloproteinases
12/05/1996WO1996038426A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists
12/05/1996WO1996038412A1 Novel compounds and anti-dermatitis drug
12/05/1996WO1996038174A1 Improved formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
12/05/1996WO1996038150A1 4.4-(disubstituted)cyclohexan-1-ols-monomers and related compounds
12/05/1996WO1996038144A1 Isothiazolones
12/05/1996WO1996038142A1 1h-4(5)-substituted imidazole derivatives
12/05/1996WO1996034953A3 Cd16-ii variants
12/05/1996CA2762921A1 Improved formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
12/05/1996CA2223276A1 Methods for in vivo reduction of nitric oxide levels and compositions useful therefor
12/05/1996CA2223091A1 Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors
12/05/1996CA2222561A1 4.4-(disubstituted)cyclohexan-1-ols-monomers and related compounds
12/05/1996CA2222147A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists
12/05/1996CA2222099A1 1h-4(5)-substituted imidazole derivatives
12/05/1996CA2220040A1 Tricyclic inhibitors of matrix metalloproteinases
12/05/1996CA2218253A1 Isothiazolones
12/04/1996EP0745596A1 Heteroaromatic oxazole compounds and use thereof
12/04/1996EP0745136A1 B7-1-specific ligands, and their use for the induction of t cell anergy
12/04/1996EP0745094A1 Superagonists and antagonists of h il-6, and 3d modelling method for their selection
12/04/1996EP0745092A1 Peptide inhibitors of urokinase receptor activity
12/04/1996EP0745075A1 6-substituted mycophenolic and derivatives with immunosuppressive activity
12/04/1996EP0745074A1 4-amino derivatives of mycophenolic acid with immunosuppressant activity
12/04/1996EP0745073A1 5-substituted derivatives of mycophenolic acid
12/04/1996EP0745072A1 4-amino derivatives of 5-substituted mycophenolic acid
12/04/1996EP0745071A1 4-amino 6-substituted mycophenolic acid and derivatives with immunosuppressive activity
1 ... 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 ... 1272